Post-approval studies (Phase 4)Not Yet RecruitingNCT07704190
What this trial is testing
Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease
Who this might be right for
Cardiorenal Metabolic SyndromeAtherosclerotic Cardiovascular DiseaseChronic Kidney Disease+5 more
Peking University Third Hospital 100